Corrigendum to "European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) [European Journal of Cancer 2024 (2024) 114062]"

Affiliations

¹ Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
² Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
³ Department of Radiation Oncology, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands.
⁴ Amsterdam UMC Location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
⁵ Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: r.vanhillegersberg@umcutrecht.nl.

Published Erratum

Tiuri E Kroese et al. Eur J Cancer. 2025.

. 2025 Oct 1:228:115712.

doi: 10.1016/j.ejca.2025.115712. Epub 2025 Sep 2.

¹ Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
² Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
³ Department of Radiation Oncology, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands.
⁴ Amsterdam UMC Location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
⁵ Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: r.vanhillegersberg@umcutrecht.nl.

No abstract available

Erratum for

European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE, Bronzwaer S, van Rossum PSN, Schoppman SF, Deseyne PRAJ, van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds JV, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, van Berge Henegouwen MI, Hulshoff MCCM, van Dieren J, Vollebergh M, van Sandick JW, Jeene P, Muijs C, Slingerland M, Voncken FEM, Hartgrink H, Creemers GJ, van der Sangen MJC, Nieuwenhuijzen GAP, Berbee M, Verheij M, Wijnhoven B, Beerepoot LV, Mohammad NH, Mook S, Ruurda JP, Kolodziejczyk P, Polkowski WP, Wyrwicz L, Alsina M, Tabernero J, Pera M, Kanonnikoff TF, Cervantes A, Nilsson M, Monig S, Wagner AD, Guckenberger M, Griffiths EA, Smyth E, Hanna GB, Markar S, Chaudry MA, Hawkins MA, Cheong E, van Laarhoven HWM, van Hillegersberg R; OMEC collaborators. Kroese TE, et al. Eur J Cancer. 2024 Jun;204:114062. doi: 10.1016/j.ejca.2024.114062. Epub 2024 Apr 16. Eur J Cancer. 2024. PMID: 38678762